Condition

Levodopa Induced Dyskinesia (LID)

ClinicalTrials.gov condition label

Clinical trials4

Recruiting0

Common interventions5

Lead sponsors shown2

Clinical trials

4 shown

Efficacy and Safety of JM-010 in PD With Levodopa-Induced DyskinesiaNCT02439203 · 2015-05-01

Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LIDNCT02153632 · 2014-07-30

Open-Label Safety Study of ADS-5102 in PD Patients With LIDNCT02202551 · 2014-07-01

ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)NCT02136914 · 2014-05-01

Common interventions

ADS-5102DRUG2 PlaceboDRUG2 amantadine HCl ERDRUG1 JM-010DRUG1 PlaceboOTHER1

Leading sponsors

Adamas Pharmaceuticals, Inc.3 Bukwang Pharmaceutical1

Trial status mix

COMPLETED3

TERMINATED1

Phase mix

PHASE33

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.